Similar Papers

Paper Title
Journal
Date
Author
What Is Driving the Legal Interest in Hepatic Encephalopathy?
Jasmohan S Bajaj ... Anthony C Stein
Clinical Gastroenterology and Hepatology | VOL. 9
Jasmohan S Bajaj, et. al.Jasmohan S Bajaj ... Anthony C Stein
09 Nov 2010
Lessons from "real life experience" of rifaximin use in the management of recurrent hepatic encephalopathy.
Fiona Chautant ... Jean-Marie Peron
World journal of hepatology | VOL. 12
Fiona Chautant, et. al.Fiona Chautant ... Jean-Marie Peron
27 Jan 2020
Real-World Experience of the One-Year Efficacy of Rifaximin Add-On to Lactulose Is Superior to Lactulose Alone in Patients with Cirrhosis Complicated with Recurrent Hepatic Encephalopathy in Taiwan.
Ching Chang ... Fang-Chen Yang
Journal of Personalized Medicine | VOL. 11
Ching Chang, et. al.Ching Chang ... Fang-Chen Yang
27 May 2021
Management of Hepatic Encephalopathy in the Hospital
Michael D Leise ... Patrick S Kamath
Mayo Clinic Proceedings | VOL. 89
Michael D Leise, et. al.Michael D Leise ... Patrick S Kamath
10 Jan 2014
View more papers

More From: Clinical Liver Disease

Paper Title
Journal
Date
Author
Not just a clearance: Surgical risk in patients with cirrhosis.
Alejandro Torres-Hernandez ... Patrick G Northup
Clinical liver disease | VOL. 23
Alejandro Torres-Hernandez, et. al.Alejandro Torres-Hernandez ... Patrick G Northup
01 Feb 2024
History of the liver-heart relationship.
Samuel S Lee ... Hongqun Liu
Clinical liver disease | VOL. 23
Samuel S Lee, et. al.Samuel S Lee ... Hongqun Liu
01 Feb 2024
What will it take to eliminate hepatitis B as a public health threat in the United States and Canada?
Su Wang ... Chari Cohen
Clinical liver disease | VOL. 23
Su Wang, et. al.Su Wang ... Chari Cohen
01 Feb 2024
Patients treated with immune checkpoint inhibitors for HCC should be considered for liver transplantation.
Media N Ismael ... Virginia Clark
Clinical liver disease | VOL. 23
Media N Ismael, et. al.Media N Ismael ... Virginia Clark
01 Feb 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.